Product nameGoat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
See all IgG + IgM secondary antibodies
DescriptionGoat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
SpecificityThis antibody reacts with heavy and light chains on mouse and rabbit IgG. It reacts with all mouse and rabbit IgG subclasses and with mouse and rabbit IgM.
Tested applicationsSuitable for: IHC-P, IHC-Frmore details
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferPBS pH7.3 with protein carrier and preservative
Concentration information loading...
Conjugation notesHRP conjugated to a polymer backbone, which is collectively conjugated to the antibody. The effect is multiple HRP molecules linked to one single antibody.
This new and innovative HRP-polymerization technology provides a significant increase in staining sensitivity when compared to other conventional HRP-conjugated secondary antibodies. Avidin-biotin blocking procedures are not necessary when using this product. The overall staining procedure uses one less reagent (streptavidin peroxidase) and rinsing step, eliminates avidin-biotin blocking procedures and may reduce overall staining time.
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Our Abpromise guarantee covers the use of ab2891 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use at an assay dependent dilution.|
|IHC-Fr||Use at an assay dependent dilution. This product is provided in a pre-diluted, ready-to-use format. Apply for 20 - 30 minutes.|
This product has been referenced in:
- Mesci P et al. Blocking Zika virus vertical transmission. Sci Rep 8:1218 (2018). Read more (PubMed: 29352135) »
- Shiryaev SA et al. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep 7:15771 (2017). Read more (PubMed: 29150641) »